| 000 | 00825nam a22002417a 4500 | ||
|---|---|---|---|
| 008 | 121122b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cVAD | ||
| 041 | _aEngels | ||
| 110 | _aEuropean Monitoring Centre for Drugs and Drug Addiction [EMCDDA] | ||
| 245 | _aEMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)- 1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) [PDF] | ||
| 260 |
_aLisbon _bEMCDDA _c2017 |
||
| 300 | _a15 p. | ||
| 490 | _aJoint reports | ||
| 650 | _adrugs | ||
| 650 | _afentanyl | ||
| 650 | _aproductinformatie | ||
| 650 | _aonderzoeksrapporten | ||
| 650 | _aopiaten | ||
| 650 | _aEuropese Unie | ||
| 650 | _aopsporing | ||
| 710 | _aEuropol | ||
| 856 | _uhttp://www.google.com/search?q=ADB-CHMINACA EMCDDA–Europol Joint Report | ||
| 999 |
_c19286 _d19286 |
||